Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DHX9 antisense RNA 1 (DHX9-AS1) is a long noncoding RNA transcribed from the antisense strand of the DHX9 locus. Long noncoding RNAs such as DHX9-AS1 do not encode proteins, but can regulate gene expression at transcriptional or post-transcriptional levels, including via epigenetic mechanisms or by acting as decoys or scaffolds for regulatory proteins. DHX9-AS1 and similar lncRNAs are increasingly recognized as having roles in cancer biology, often affecting cell proliferation, apoptosis, metastasis, and other malignant behaviors, though details for DHX9-AS1 specifically remain limited in comparison to better-characterized lncRNAs. Importantly, DHX9-AS1 is not a protein, receptor, or enzyme, and does not directly interact with drugs, though it may one day be considered for drug discovery efforts in RNA therapeutics.
Not applicable for drugs; functions by regulating transcription and possibly modulating chromatin state.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DHX9 antisense RNA 1 (DHX9-AS1).